Krsnaa Diagnostics Ltd
Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns.[1]
- Market Cap ₹ 2,688 Cr.
- Current Price ₹ 826
- High / Low ₹ 1,044 / 626
- Stock P/E 31.9
- Book Value ₹ 277
- Dividend Yield 0.33 %
- ROCE 12.5 %
- ROE 9.29 %
- Face Value ₹ 5.00
Pros
Cons
- Stock is trading at 2.99 times its book value
- Promoter holding is low: 27.1%
- Company has a low return on equity of 8.57% over last 3 years.
- Dividend payout has been low at 12.7% of profits over last 3 years
- Company has high debtors of 152 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Part of BSE Healthcare BSE SmallCap BSE Allcap
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|
36 | 57 | 108 | 147 | 258 | 396 | 455 | 464 | 590 | 682 | 694 | |
35 | 42 | 169 | 87 | 373 | 302 | 320 | 340 | 444 | 485 | 490 | |
Operating Profit | 0 | 15 | -62 | 60 | -114 | 94 | 135 | 124 | 146 | 197 | 204 |
OPM % | 1% | 26% | -57% | 41% | -44% | 24% | 30% | 27% | 25% | 29% | 29% |
3 | 4 | 3 | 2 | 13 | 265 | 15 | 19 | 17 | 26 | 22 | |
Interest | 6 | 6 | 8 | 16 | 25 | 26 | 18 | 8 | 16 | 25 | 26 |
Depreciation | 5 | 10 | 18 | 26 | 32 | 37 | 41 | 54 | 75 | 88 | 88 |
Profit before tax | -7 | 2 | -84 | 21 | -158 | 295 | 90 | 82 | 72 | 110 | 112 |
Tax % | 6% | 8% | -29% | 40% | -29% | 37% | 21% | 23% | 19% | 24% | |
-8 | 2 | -60 | 12 | -112 | 185 | 71 | 64 | 59 | 83 | 84 | |
EPS in Rs | -15.05 | 4.01 | -116.54 | 24.15 | -216.83 | 284.73 | 22.52 | 20.23 | 18.14 | 25.65 | 26.05 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 11% | 14% | 14% | 11% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 21% |
3 Years: | 14% |
TTM: | 12% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 22% |
3 Years: | 4% |
TTM: | 37% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 18% |
1 Year: | 0% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 9% |
Last Year: | 9% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 5 | 5 | 5 | 5 | 6 | 16 | 16 | 16 | 16 | |
Reserves | 4 | 6 | 43 | -217 | -17 | 671 | 727 | 799 | 877 | |
131 | 102 | 330 | 246 | 474 | 41 | 32 | 160 | 202 | ||
24 | 63 | 115 | 596 | 146 | 149 | 134 | 197 | 188 | ||
Total Liabilities | 163 | 176 | 493 | 630 | 609 | 877 | 909 | 1,172 | 1,283 | |
59 | 116 | 223 | 275 | 309 | 386 | 471 | 647 | 668 | ||
CWIP | 20 | 6 | 42 | 9 | 4 | 28 | 25 | 10 | 3 | |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32 | |
85 | 53 | 228 | 345 | 297 | 463 | 413 | 514 | 581 | ||
Total Assets | 163 | 176 | 493 | 630 | 609 | 877 | 909 | 1,172 | 1,283 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|
59 | 61 | 38 | 119 | 129 | 75 | 24 | 89 | |||
-53 | -201 | -77 | -67 | -241 | -109 | -129 | -102 | |||
-37 | 145 | 6 | 20 | 176 | -33 | 84 | 14 | |||
Net Cash Flow | -31 | 4 | -33 | 71 | 64 | -66 | -20 | 1 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 87 | 91 | 140 | 87 | 69 | 48 | 59 | 110 | 152 | |
Inventory Days | 21 | 24 | 89 | |||||||
Days Payable | 76 | 99 | 878 | |||||||
Cash Conversion Cycle | 32 | 15 | -650 | 87 | 69 | 48 | 59 | 110 | 152 | |
Working Capital Days | -428 | -119 | -234 | -133 | -82 | -21 | 16 | -18 | 28 | |
ROCE % | 7% | -65% | 129% | 18% | 12% | 10% | 13% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
2d - One-on-one investor/analyst meetings in Pune on Oct 07, 2025; physical, no UPSI intended.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
3 Oct - Submission of Regulation 74(5) confirmation certificate for quarter ended Sept 30, 2025.
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 27 Sep
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
27 Sep - Krsnaa Diagnostics investor meetings in Singapore on Sept 29, 2025 with institutional investors; no unpublished price sensitive information.
-
Approval For Continuation Of Directorship Of Mr. Chetan Desai (DIN: 03595319) As A Non-Executive Independent Director Of The Company Post Attaining The Age Of 75 Years.
26 Sep - Shareholders approved Chetan Desai’s continuation as Non-Executive Independent Director until April 2026 (approved Sept 25, 2025).
Annual reports
Concalls
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Oct 2024TranscriptNotesPPT
-
Aug 2024Transcript PPT
-
Aug 2024TranscriptNotesPPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT REC
-
Jun 2022Transcript PPT
-
Mar 2022TranscriptNotesPPT
-
Feb 2022Transcript PPT
-
Nov 2021TranscriptPPT
-
Oct 2021Transcript PPT
Business Profile[1]
Krsnaa Diagnostics Limited is one of India’s largest differentiated diagnostic service providers with a Pan-India presence in Radiology and Pathology. It has established a Pan India presence through partnerships with government hospitals and operates a substantial number of CT and MRI centers.